Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Norovirus GI.1 VP1 P domain is the surface-exposed, protruding region of the major capsid protein (VP1) of the Norwalk virus, the prototype strain for Genogroup I noroviruses (PubMed: 12915522). This domain is critical for viral pathogenesis as it contains the binding pockets for histo-blood group antigens (HBGAs), which serve as the primary attachment factors on human intestinal cells (PubMed: 24915460). Structurally, the P domain is divided into P1 and P2 subdomains; the P2 subdomain is the most distal part of the capsid and contains the highly variable loops that dictate host specificity and serve as the main targets for neutralizing antibodies (UniProt: P03555). Because it mediates the initial stages of viral entry, the P domain is a primary focus for the development of vaccines, such as virus-like particles (VLPs), and small-molecule entry inhibitors (PubMed: 25817401). Current therapeutic strategies aim to block the P domain-HBGA interaction using carbohydrate mimetics or to elicit broad-spectrum neutralizing antibodies that can overcome the virus's significant antigenic diversity (PubMed: 30104445).
Steric or competitive inhibition of the interaction between the viral P2 subdomain and host histo-blood group antigens (HBGAs), preventing viral attachment and entry (PubMed: 30104445).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norovirus GI.1 major capsid protein VP1 P domain (GI.1 VP1 P domain).